Decreased anti-hepatitis C virus titer and associated factors in chronic hepatitis C patients after sustained virological response: a prospective study (Q43041377)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2012

Language	Label	Description	Also known as
English	Decreased anti-hepatitis C virus titer and associated factors in chronic hepatitis C patients after sustained virological response: a prospective study	scientific article published in June 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Decreased anti-hepatitis C virus titer and associated factors in chronic hepatitis C patients after sustained virological response: a prospective study (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

author name string

Kwong-Ming Kee

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Jing-Houng Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Chao-Hung Hung

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Chien-Hung Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Chuang-Mo Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kuo-Chin Chang

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Po-Lin Tseng

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Yi-Hao Yen

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Chih-Yun Lin

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sheng-Nan Lu

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1106-1111

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Diagnosis, management, and treatment of hepatitis C: an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Long-term effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1,386-patient study from Taiwan.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Hepatitis C virus viremia following clinical resolution of acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Long-term follow-up after successful interferon therapy of acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Identified cases of acute hepatitis C from computerized laboratory database: a hospital-based epidemiological and clinical study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Histological improvement of chronic liver disease after spontaneous serum hepatitis C virus clearance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Hepatitis C virus infection among teenagers in an endemic township in Taiwan: epidemiological and clinical follow-up studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

A higher than expected recovery rate from hepatitis C infection amongst adolescents: a community study in a hepatitis C-endemic township in Taiwan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Prevalence and manifestations of hepatitis C seropositivity in children in an endemic area

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Complete or partial seroreversion in immunocompetent individuals after self-limited HCV infection: consequences for transfusion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Full or partial seroreversion in patients infected by hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Lymphocyte T helper-specific reactivity in sustained responders to interferon and ribavirin with negativation (seroreversion) of anti-hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in Taiwan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Virus-specific antibody titres in different phases of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Reactivity to c33c antigen as a marker of hepatitis C virus multiplication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

A SAS Procedure Based on Mixture Models for Estimating Developmental Trajectories

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06946.X

21 January 2018

Identifiers

10.1111/J.1440-1746.2011.06946.X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43041377&oldid=1978325316"